1 / 11

Malignant hyperthermia

Malignant hyperthermia. Dr S Spijkerman. Pathogenesis. P harmacogenetic disorder A utosomal dominant inheritance Patients inherit a defected ryanodine 1 (RYR1) receptor.

xue
Download Presentation

Malignant hyperthermia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Malignant hyperthermia Dr S Spijkerman

  2. Pathogenesis

  3. Pharmacogenetic disorder • Autosomal dominant inheritance • Patients inherit a defected ryanodine 1 (RYR1) receptor. • This receptor is responsible for regulating the calcium flow from the sarcoplasmic reticulum (SR) to the cytoplasm. • When a MH susceptible patient is exposed to a triggering anaesthetic agent (suxamethonium or inhalants), continuous activation of the Ryanodine 1 (RY1) receptor occurs, resulting in supraphysiological levels of sarcoplasmic reticulum calcium release with a compensatory increase in activity of the SR calcium re-uptake pump (an ATP dependent pump). • The increase in utilization of ATP stimulates metabolism, resulting in increased oxygen consumption, increased carbon dioxide production, thermogenesis and sympathetic stimulation (tachycardia and arrhythmias) • As ATP demand exceeds supply, muscle rigidity is seen with subsequent rhabdomyolysis, with release of potassium and myoglobin • This is followed by multi-organ failure and death.

  4. MH triggers N2O is safe

  5. Clinical presentation

  6. DDx

  7. Treatment

  8. Treatment (cont)

  9. Treatment (cont)

  10. Anaesthesia for MH sensitive patient

More Related